NCT07100574 Bacteria in Dental Plaque and Atheroma Plaque
| NCT ID | NCT07100574 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Istanbul Saglik Bilimleri University |
| Condition | Gingival Inflammation |
| Study Type | OBSERVATIONAL |
| Enrollment | 60 participants |
| Start Date | 2024-12-10 |
| Primary Completion | 2025-12-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 60 participants in total. It began in 2024-12-10 with a primary completion date of 2025-12-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Periodontitis is considered a focus of infection where oral bacteria, bacterial by-products or inflammatory mediators can interact with other parts of the organism via the blood. Periodontal pathogen components such as DNA, RNA or specific antigens of P. gingivalis, Aggregatibacter actinomycetemcomitans (A. actinomycetemcomitans), Treponema denticola (T. denticola), Fusobacterium nucleatum (F. nucleatum) or Campylobacter rectus have been isolated from different tissues such as atheroma plaques, placenta, amniotic sac and respiratory tract. It has been reported that periodontitis may contribute to endothelial dysfunction leading to the formation of atherosclerosis.
Eligibility Criteria
Inclusion Criteria: * Diagnosed with endarterectomy * Not receiving chemotherapy * Not having received this treatment before Exclusion Criteria: * Having systemic infection * Patients with severe heart disease
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07100574 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 85 Years, studying Gingival Inflammation. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07100574 currently recruiting?
Yes, NCT07100574 is actively recruiting participants. Contact the research team at draysetoraman@gmail.com for enrollment information.
Where is the NCT07100574 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07100574 clinical trial?
NCT07100574 is sponsored by Istanbul Saglik Bilimleri University. The trial plans to enroll 60 participants.